AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2023 Issue 4; New/Revised ICD-10-PCS Codes Section X – New Technology

Introduction of New Therapeutic Substances

Nine new substance values were added to table XW0, Introduction, Anatomical Regions, for the substances listed below. Please note that all of the substances have a qualifier value of 9 New Technology Group 9.Device/Substance/Technology J Quizartinib Antineoplastic K Sulbactam-Durlobactam L Elranatamab Antineoplastic N SER-109 P Glofitamab Antineoplastic Q Posoleucel R Rezafungin S Epcoritamab Monocolonal Antibody T Mephalan Hydrochloride Antineoplastic QuizartinibQuizartinib is used to treat adult patients with newly diagnosed acute myeloid leukemia (AML) that is FMS-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD) positive. This drug is a small molecule novel tyrosine kinase inhibitor expressly developed as a...

To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .


  • The official AHA publication for ICD-10-CM and ICD-10-PCS coding guidelines and advice
  • Current newsletters added each quarter
  • Full Archives - over 3100 articles
  • ALL years/issues back to 1984 organized by year and issue
  • Includes ICD-10-CM/PCS Articles since 2013
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - ICD-10-CM/PCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.